What’s Your WhEYE?
Please check back later for more content.
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
FDA requires NAION warning across the GLP-1 receptor agonist class
2
Viridian's VRDN-008 sustains IgG suppression through 8 weeks in phase 1
3
VERONA: Katherine Talcott, MD, on early gains with a TKI insert in DME
4
Selecting Initial Therapy in Newly Diagnosed Wet AMD
5